UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005005
Receipt number R000005946
Scientific Title The association between lifestyle factors and DNA methylation levels in gastric mucosa of participants in cancer screening
Date of disclosure of the study information 2011/02/02
Last modified on 2015/11/19 15:26:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The association between lifestyle factors and DNA methylation levels in gastric mucosa of participants in cancer screening

Acronym

Lifestyle factors and DNA methylation levels in gastric mucosa

Scientific Title

The association between lifestyle factors and DNA methylation levels in gastric mucosa of participants in cancer screening

Scientific Title:Acronym

Lifestyle factors and DNA methylation levels in gastric mucosa

Region

Japan


Condition

Condition

Healthy

Classification by specialty

Gastroenterology Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To investigate the association between lifestyle factors and DNA methylation levels in gastric mucosa

Basic objectives2

Others

Basic objectives -Others

To investigate the association with DNA methylation levels in gastric mucosa, after eradicating current Helicobacter pylori infection.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

DNA methylation levels in gastric mucosa

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Treatment to eradicate Helicobacter pylori in infected participants: 7-day course of lansoprazole, clarithromycin, and amoxicillin

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Examinees who 1) underwent upper gastrointestinal endoscopy as part of the cancer screening program provided by the Research Center for Cancer Prevention and Screening of the National Cancer Center and 2) gave written informed consent to participate in the study

Key exclusion criteria

1) History of treatment for Helicobacter pylori infection, 2) use of nonsteroidal anti-inflammatory drugs during previous 30 days, 3) upper gastrointestinal endoscopy during previous 1 year, 4) >=10% weight loss during previous 3 months, 5) history of gastric cancer, 6) history of gastrectomy, antireflux procedure, or vagotomy, 7) pregnancy

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shoichiro Tsugane

Organization

Research Center for Cancer Prevention and Screening, National Cancer Center

Division name

Epidemiology and Prevention Group

Zip code


Address

5-1-1 Tsukiji, Chuo-ku Tokyo

TEL

03-3542-2511

Email

kenshin@ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Taichi Shimazu

Organization

Research Center for Cancer Prevention and Screening, National Cancer Center

Division name

Epidemiology and Prevention Group

Zip code


Address

5-1-1 Tsukiji, Chuo-ku Tokyo

TEL

03-3542-2511

Homepage URL

http://epi.ncc.go.jp/mstudy/766/3706.html

Email

kenshin@ncc.go.jp


Sponsor or person

Institute

National Cancer Center

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

Ministry of Education, Culture, Sports, Science and Technology


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立研究開発法人国立がん研究センター(東京)


Other administrative information

Date of disclosure of the study information

2011 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

http://www.ncbi.nlm.nih.gov/pubmed/26354778

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 01 Month 30 Day

Date of IRB


Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date

2010 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 03 Month 01 Day

Date trial data considered complete

2013 Year 03 Month 01 Day

Date analysis concluded

2013 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 02 Month 02 Day

Last modified on

2015 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005946


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name